Current Neurovascular Research

Current Neurovascular Research

Editor-in-Chief

ISSN (Print): 1567-2026
ISSN (Online): 1875-5739

Back Subscribe
Research Article

Headache and Intracranial Aneurysm: A Bidirectional Mendelian Randomization Study

Author(s): Chunlin Renorcid of author, Qian Gao, Xinmin Li, Fangjie Yang, Jing Wang, Pengxue Guo, Zhenfei Duan, YuTing Kong, MengYao Bi, Lidian Chen and Yasu Zhang*

Volume 22, Issue 1, 2025

Published on: 04 June, 2025

Page: [40 - 52] Pages: 13

DOI: 10.2174/0115672026380807250530112524

Price: $65

Become a Editorial Board Member
Become a Reviewer
Become a Editor
Become a Section Editor

Abstract

Introduction: Headaches affect up to 95% of individuals during their lifetime and are a major global cause of disability. Intracranial Aneurysm (IA) is a cerebrovascular disorder affecting approximately 3.2% of the general population. Observational studies have suggested an association between headaches and IA, but the causal relationship remains unclear. This Mendelian Randomization (MR) analysis aims to elucidate the causal relationship between headaches and IA.

Methods: A two-sample bidirectional Mendelian Randomization (MR) analysis was performed using publicly available Genome-Wide Association Study (GWAS) data to assess the causal relationships between IA and four headache subtypes, namely, Chronic Headache (CH), Tension- Type Headache (TTH), Migraine Without Aura (MO), and Migraine With Aura (MA). The inverse variance weighted method was employed as the primary method, with sensitivity analyses conducted to evaluate the robustness of the results. Mediation analysis was performed to investigate the potential mediating role of hypertension.

Results: The MR analysis revealed that MO was associated with an increased risk of aneurysmal Subarachnoid Hemorrhage (aSAH) (Odds Ratio [OR] = 1.422, 95% Confidence Interval [CI]: 1.0541.918, and P = 0.021), while MA (OR = 1.527, 95% CI: 1.1152.091, and P = 0.008) was associated with an elevated risk of unruptured IA (uIA). Mediation analysis indicated that hypertension did not significantly mediate these associations.

Discussion: This study highlights the potential role of MO in aSAH and MA in uIA, where hypertension does not serve as a significant mediator. Further research is necessary to investigate the underlying mechanisms, which may offer valuable insights into the prevention and management of IA.

Conclusion: Bidirectional MR analysis of four headache subtypes and IA provides evidence that MO is associated with an increased risk of aSAH, while MA is linked to a higher risk of uIA. These findings contribute to a better understanding of the complex relationship between headaches and IA.

Keywords: Headache, migraine, intracranial aneurysm, mendelian randomization, single nucleotide polymorphism, causal link.

[1]
Xu Z, Rui YN, Hagan JP, Kim DH. Intracranial aneurysms: Pathology, genetics, and molecular mechanisms. Neuromolecular Med 2019; 21(4): 325-43.
[http://dx.doi.org/10.1007/s12017-019-08537-7] [PMID: 31055715]
[2]
Macdonald RL, Schweizer TA. Spontaneous subarachnoid haemorrhage. Lancet 2017; 389(10069): 655-66.
[http://dx.doi.org/10.1016/S0140-6736(16)30668-7] [PMID: 27637674]
[3]
Vlak MHM, Algra A, Brandenburg R, Rinkel GJE. Prevalence of unruptured intracranial aneurysms, with emphasis on sex, age, comorbidity, country, and time period: A systematic review and meta-analysis. Lancet Neurol 2011; 10(7): 626-36.
[http://dx.doi.org/10.1016/S1474-4422(11)70109-0] [PMID: 21641282]
[4]
Rinkel GJE, Algra A. Long-term outcomes of patients with aneurysmal subarachnoid haemorrhage. Lancet Neurol 2011; 10(4): 349-56.
[http://dx.doi.org/10.1016/S1474-4422(11)70017-5] [PMID: 21435599]
[5]
Brinjikji W, Zhu YQ, Lanzino G, et al. Risk factors for growth of intracranial aneurysms: A systematic review and meta-analysis. AJNR Am J Neuroradiol 2016; 37(4): 615-20.
[http://dx.doi.org/10.3174/ajnr.A4575] [PMID: 26611992]
[6]
Jin D, Song C, Leng X, Han P. A systematic review and meta-analysis of risk factors for unruptured intracranial aneurysm growth. Int J Surg 2019; 69: 68-76.
[http://dx.doi.org/10.1016/j.ijsu.2019.07.023] [PMID: 31356963]
[7]
Salimi Ashkezari SF, Mut F, Chung BJ, et al. Hemodynamics in aneurysm blebs with different wall characteristics. J Neurointerv Surg 2021; 13(7): 642-6.
[http://dx.doi.org/10.1136/neurintsurg-2020-016601] [PMID: 33020208]
[8]
Wang J, Wei L, Lu H, Zhu Y. Roles of inflammation in the natural history of intracranial saccular aneurysms. J Neurol Sci 2021; 424: 117294.
[http://dx.doi.org/10.1016/j.jns.2020.117294] [PMID: 33799211]
[9]
Al Fauzi A, Rahmatullah MI, Suroto NS, et al. Comparison of outcomes between clipping and endovascular coiling in anterior choroidal artery aneurysm: A systematic review. Neurosurg Rev 2023; 46(1): 276.
[http://dx.doi.org/10.1007/s10143-023-02179-x] [PMID: 37861756]
[10]
Javadnia P, Bahadori AR, Naghavi E, et al. Comparative efficacy and safety of therapeutic strategies for mirror aneurysms: A systematic review and meta-analysis. Neurosurg Rev 2024; 47(1): 900.
[http://dx.doi.org/10.1007/s10143-024-03138-w] [PMID: 39666217]
[11]
Naggara ON, White PM, Guilbert F, Roy D, Weill A, Raymond J. Endovascular treatment of intracranial unruptured aneurysms: Systematic review and meta-analysis of the literature on safety and efficacy. Radiology 2010; 256(3): 887-97.
[http://dx.doi.org/10.1148/radiol.10091982] [PMID: 20634431]
[12]
Sauvigny J, Drexler R, Pantel TF, et al. Microsurgical clipping of unruptured anterior circulation aneurysms—a global multicenter investigation of perioperative outcomes. Neurosurgery 2024; 94(6): 1218-26.
[http://dx.doi.org/10.1227/neu.0000000000002829] [PMID: 38240568]
[13]
Thompson BG, Brown RD, Amin-Hanjani S, et al. Guidelines for the management of patients with unruptured intracranial aneurysms. Stroke 2015; 46(8): 2368-400.
[http://dx.doi.org/10.1161/STR.0000000000000070] [PMID: 26089327]
[14]
Stovner LJ, Nichols E, Steiner TJ, et al. Global, regional, and national burden of migraine and tension-type headache, 1990–2016: A systematic analysis for the global burden of disease study 2016. Lancet Neurol 2018; 17(11): 954-76.
[http://dx.doi.org/10.1016/S1474-4422(18)30322-3] [PMID: 30353868]
[15]
Yang Y, Cao Y. Rising trends in the burden of migraine and tension-type headache among adolescents and young adults globally, 1990 to 2019. J Headache Pain 2023; 24(1): 94.
[http://dx.doi.org/10.1186/s10194-023-01634-w] [PMID: 37495946]
[16]
The international classification of headache disorders, 3rd edition. Cephalalgia 2018; 38(1): 1-211.
[http://dx.doi.org/10.1177/0333102417738202]
[17]
Vlak MHM, Rinkel GJE, Greebe P, Algra A. Risk of rupture of an intracranial aneurysm based on patient characteristics: A case-control study. Stroke 2013; 44(5): 1256-9.
[http://dx.doi.org/10.1161/STROKEAHA.111.000679] [PMID: 23520239]
[18]
Lamsam L, Bhambhvani HP, Thomas A, Ratliff JK, Moore JM. Aneurysmal subarachnoid hemorrhage in patients with migraine and tension headache: A cohort comparison study. J Clin Neurosci 2020; 79: 90-4.
[http://dx.doi.org/10.1016/j.jocn.2020.07.017] [PMID: 33070926]
[19]
Lebedeva ER, Gurary NM, Sakovich VP, Olesen J. Migraine before rupture of intracranial aneurysms. J Headache Pain 2013; 14(1): 15.
[http://dx.doi.org/10.1186/1129-2377-14-15] [PMID: 23574797]
[20]
Wan Z, Meng H, Xu N, et al. Clinical characteristics associated with sentinel headache in patients with unruptured intracranial aneurysms. Interv Neuroradiol 2021; 27(4): 497-502.
[http://dx.doi.org/10.1177/1591019920971977] [PMID: 33148104]
[21]
Lebedeva ER, Busygina AV, Kolotvinov VS, Sakovich VP, Olesen J. Remission of migraine after clipping of saccular intracranial aneurysms. Acta Neurol Scand 2015; 131(2): 120-6.
[http://dx.doi.org/10.1111/ane.12292] [PMID: 25288229]
[22]
Swerdlow DI, Kuchenbaecker KB, Shah S, et al. Selecting instruments for Mendelian randomization in the wake of genome-wide association studies. Int J Epidemiol 2016; 45(5): 1600-16.
[http://dx.doi.org/10.1093/ije/dyw088] [PMID: 27342221]
[23]
Richmond RC, Davey Smith G. Mendelian randomization: Concepts and scope. Cold Spring Harb Perspect Med 2022; 12(1): a040501.
[http://dx.doi.org/10.1101/cshperspect.a040501] [PMID: 34426474]
[24]
Pingault JB, O’Reilly PF, Schoeler T, Ploubidis GB, Rijsdijk F, Dudbridge F. Using genetic data to strengthen causal inference in observational research. Nat Rev Genet 2018; 19(9): 566-80.
[http://dx.doi.org/10.1038/s41576-018-0020-3] [PMID: 29872216]
[25]
Ma J, Zong K, Wang Y, et al. Exploring the impact of dietary factors on intracranial aneurysm risk: insights from Mendelian randomization analysis. Neurol Res 2025; 12: 1-9.
[http://dx.doi.org/10.1080/01616412.2025.2477240] [PMID: 40071388]
[26]
Tan J, Zhu H, Zeng Y, Li J, Zhao Y, Li M. Modifiable lifestyle factors and risk of intracranial aneurysm: A univariate and multivariate Mendelian randomisation study. Neuroscience 2025; 566: 9-16.
[http://dx.doi.org/10.1016/j.neuroscience.2024.12.034] [PMID: 39706516]
[27]
Liu J, Yuan B, Wang Y, Yan J. Bi-directional effects between inflammatory molecules and intracranial aneurysm. Neurosurg Rev 2024; 47(1): 865.
[http://dx.doi.org/10.1007/s10143-024-03070-z] [PMID: 39570436]
[28]
Kowalska M, Prendecki M, Piekut T, Kozubski W, Dorszewska J. Migraine: Calcium channels and glia. Int J Mol Sci 2021; 22(5): 2688.
[http://dx.doi.org/10.3390/ijms22052688] [PMID: 33799975]
[29]
Gonzalez-Martinez A, Ray JC, Haghdoost F, et al. Time and headache: Insights into timing processes in primary headache disorders for diagnosis, underlying pathophysiology and treatment implications. Cephalalgia 2024; 44(11): 03331024241297652.
[http://dx.doi.org/10.1177/03331024241297652] [PMID: 39558611]
[30]
Parsaei M, Taebi M, Arvin A, Moghaddam HS. Brain structural and functional abnormalities in patients with tension‐type headache: A systematic review of magnetic resonance imaging studies. J Neurosci Res 2024; 102(1): e25294.
[http://dx.doi.org/10.1002/jnr.25294] [PMID: 38284839]
[31]
Paolucci M, Altamura C, Vernieri F. The role of endothelial dysfunction in the pathophysiology and cerebrovascular effects of migraine: A narrative review. J Clin Neurol 2021; 17(2): 164-75.
[http://dx.doi.org/10.3988/jcn.2021.17.2.>164] [PMID: 33835736]
[32]
Skrivankova VW, Richmond RC, Woolf BAR, et al. Strengthening the reporting of observational studies in epidemiology using mendelian randomization. JAMA 2021; 326(16): 1614-21.
[http://dx.doi.org/10.1001/jama.2021.18236] [PMID: 34698778]
[33]
Zorina-Lichtenwalter K, Bango CI, Van Oudenhove L, et al. Genetic risk shared across 24 chronic pain conditions: Identification and characterization with genomic structural equation modeling. Pain 2023; 164(10): 2239-52.
[http://dx.doi.org/10.1097/j.pain.0000000000002922] [PMID: 37219871]
[34]
Jiang L, Zheng Z, Fang H, Yang J. A generalized linear mixed model association tool for biobank-scale data. Nat Genet 2021; 53(11): 1616-21.
[http://dx.doi.org/10.1038/s41588-021-00954-4] [PMID: 34737426]
[35]
Kurki MI, Karjalainen J, Palta P, et al. FinnGen provides genetic insights from a well-phenotyped isolated population. Nature 2023; 613(7944): 508-18.
[http://dx.doi.org/10.1038/s41586-022-05473-8] [PMID: 36653562]
[36]
Bakker MK, van der Spek RAA, van Rheenen W, et al. Genome-wide association study of intracranial aneurysms identifies 17 risk loci and genetic overlap with clinical risk factors. Nat Genet 2020; 52(12): 1303-13.
[http://dx.doi.org/10.1038/s41588-020-00725-7] [PMID: 33199917]
[37]
Loya H, Kalantzis G, Cooper F, Palamara PF. A scalable variational inference approach for increased mixed-model association power. Nat Genet 2025; 57(2): 461-8.
[http://dx.doi.org/10.1038/s41588-024-02044-7] [PMID: 39789286]
[38]
Machiela MJ, Chanock SJ. LDlink: A web-based application for exploring population-specific haplotype structure and linking correlated alleles of possible functional variants. Bioinformatics 2015; 31(21): 3555-7.
[http://dx.doi.org/10.1093/bioinformatics/btv402] [PMID: 26139635]
[39]
Lin SH, Brown DW, Machiela MJ. LDtrait: An online tool for identifying published phenotype associations in linkage disequilibrium. Cancer Res 2020; 80(16): 3443-6.
[http://dx.doi.org/10.1158/0008-5472.CAN-20-0985] [PMID: 32606005]
[40]
Burgess S, Dudbridge F, Thompson SG. Combining information on multiple instrumental variables in Mendelian randomization: Comparison of allele score and summarized data methods. Stat Med 2016; 35(11): 1880-906.
[http://dx.doi.org/10.1002/sim.6835] [PMID: 26661904]
[41]
Bowden J, Davey Smith G, Haycock PC, Burgess S. Consistent estimation in mendelian randomization with some invalid instruments using a weighted median estimator. Genet Epidemiol 2016; 40(4): 304-14.
[http://dx.doi.org/10.1002/gepi.21965] [PMID: 27061298]
[42]
Kang H, Zhang A, Cai TT, Small DS. Instrumental variables estimation with some invalid instruments and its application to mendelian randomization. J Am Stat Assoc 2016; 111(513): 132-44.
[http://dx.doi.org/10.1080/01621459.2014.994705]
[43]
Verbanck M, Chen CY, Neale B, Do R. Detection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases. Nat Genet 2018; 50(5): 693-8.
[http://dx.doi.org/10.1038/s41588-018-0099-7] [PMID: 29686387]
[44]
Bowden J, Davey Smith G, Burgess S. Mendelian randomization with invalid instruments: Effect estimation and bias detection through Egger regression. Int J Epidemiol 2015; 44(2): 512-25.
[http://dx.doi.org/10.1093/ije/dyv080] [PMID: 26050253]
[45]
Bowden J, Del Greco MF, Minelli C, et al. Improving the accuracy of two-sample summary-data Mendelian randomization: Moving beyond the NOME assumption. Int J Epidemiol 2019; 48(3): 728-42.
[http://dx.doi.org/10.1093/ije/dyy>258] [PMID: 30561657]
[46]
Velickovic Ostojic L, Liang JW, Sheikh HU, Dhamoon MS. Impact of aura and status migrainosus on readmissions for vascular events after migraine admission. Headache 2018; 58(7): 964-72.
[http://dx.doi.org/10.1111/head.13347] [PMID: 29933509]
[47]
Schwedt TJ, Gereau RW, Frey K, Kharasch ED. Headache outcomes following treatment of unruptured intracranial aneurysms: A prospective analysis. Cephalalgia 2011; 31(10): 1082-9.
[http://dx.doi.org/10.1177/0333102411398155] [PMID: 21398420]
[48]
Gu DQ, Duan CZ, Li XF, He XY, Lai LF, Su SX. Effect of endovascular treatment on headache in elderly patients with unruptured intracranial aneurysms. AJNR Am J Neuroradiol 2013; 34(6): 1227-31.
[http://dx.doi.org/10.3174/ajnr.A3353] [PMID: 23221953]
[49]
Zhang L, Wang Y, Zhang Q, et al. Headache improvement after intracranial endovascular procedures in Chinese patients with unruptured intracranial aneurysm. Medicine 2017; 96(6): e6084.
[http://dx.doi.org/10.1097/MD.0000000000006084] [PMID: 28178166]
[50]
Gan Q, Song E, Zhang L, et al. The role of hypertension in the relationship between leisure screen time, physical activity and migraine: A 2-sample Mendelian randomization study. J Headache Pain 2024; 25(1): 122.
[http://dx.doi.org/10.1186/s10194-024-01820-4] [PMID: 39048956]
[51]
Mazzacane F, Vaghi G, Cotta Ramusino M, Perini G, Costa A. Arterial hypertension in the chronic evolution of migraine: Bystander or risk factor? An overview. J Headache Pain 2024; 25(1): 13.
[http://dx.doi.org/10.1186/s10194-024-01720-7] [PMID: 38311745]
[52]
Backes D, Rinkel GJE, Laban KG, Algra A, Vergouwen MDI. Patient- and aneurysm-specific risk factors for intracranial aneurysm growth. Stroke 2016; 47(4): 951-7.
[http://dx.doi.org/10.1161/STROKEAHA.115.012162] [PMID: 26906920]
[53]
Kang H, Peng T, Qian Z, et al. Impact of hypertension and smoking on the rupture of intracranial aneurysms and their joint effect. Neurol Neurochir Pol 2015; 49(2): 121-5.
[http://dx.doi.org/10.1016/j.pjnns.2015.03.005] [PMID: 25890927]
[54]
Entonen AH, Suominen SB, Sillanmäki LH, et al. Prevalent migraine as a predictor of incident hypertension. Eur J Public Health 2022; 32(2): 297-301.
[http://dx.doi.org/10.1093/eurpub/ckab>219] [PMID: 35021188]
[55]
Entonen AH, Suominen SB, Korkeila K, et al. Migraine predicts hypertension--a cohort study of the Finnish working-age population. Eur J Public Health 2014; 24(2): 244-8.
[http://dx.doi.org/10.1093/eurpub/ckt141] [PMID: 24065369]
[56]
Rist PM, Winter AC, Buring JE, Sesso HD, Kurth T. Migraine and the risk of incident hypertension among women. Cephalalgia 2018; 38(12): 1817-24.
[http://dx.doi.org/10.1177/0333102418756865] [PMID: 29388437]
[57]
Kareff H, Sharpe S, Gupta C, Friedman BW. Treatment of headache reduces blood pressure among most patients with migraine and elevated blood pressure. Am J Emerg Med 2025; 91: 55-8.
[http://dx.doi.org/10.1016/j.ajem.2025.02.017] [PMID: 39987628]
[58]
Sumelahti ML, Sumanen MS, Mattila KJ, Sillanmäki L, Sumanen M. Stroke and cardiovascular risk factors among working-aged Finnish migraineurs. BMC Public Health 2021; 21(1): 1088.
[http://dx.doi.org/10.1186/s12889-021-11006-1] [PMID: 34098909]
[59]
Gudmundsson LS, Thorgeirsson G, Sigfusson N, Sigvaldason H, Johannsson M. Migraine patients have lower systolic but higher diastolic blood pressure compared with controls in a population-based study of 21,537 subjects. The reykjavik study. Cephalalgia 2006; 26(4): 436-44.
[http://dx.doi.org/10.1111/j.1468-2982.2005.01057.x] [PMID: 16556245]
[60]
Benseñor IM, Goulart AC, Lotufo PA, Menezes PR, Scazufca M. Cardiovascular risk factors associated with migraine among the elderly with a low income: The São Paulo ageing & health study (SPAH). Cephalalgia 2011; 31(3): 331-7.
[http://dx.doi.org/10.1177/0333102410380754] [PMID: 20693229]
[61]
Close LN, Eftekhari S, Wang M, Charles AC, Russo AF. Cortical spreading depression as a site of origin for migraine: Role of CGRP. Cephalalgia 2019; 39(3): 428-34.
[http://dx.doi.org/10.1177/0333102418774299] [PMID: 29695168]
[62]
Dehghani A, Schenke M, van Heiningen SH, Karatas H, Tolner EA, van den Maagdenberg AMJM. Optogenetic cortical spreading depolarization induces headache-related behaviour and neuroinflammatory responses some prolonged in familial hemiplegic migraine type 1 mice. J Headache Pain 2023; 24(1): 96.
[http://dx.doi.org/10.1186/s10194-023-01628-8] [PMID: 37495957]
[63]
Shibata M, Suzuki N. Exploring the role of microglia in cortical spreading depression in neurological disease. J Cereb Blood Flow Metab 2017; 37(4): 1182-91.
[http://dx.doi.org/10.1177/0271678X17690537] [PMID: 28155572]
[64]
Bolay H, Reuter U, Dunn AK, Huang Z, Boas DA, Moskowitz MA. Intrinsic brain activity triggers trigeminal meningeal afferents in a migraine model. Nat Med 2002; 8(2): 136-42.
[http://dx.doi.org/10.1038/nm0202-136] [PMID: 11821897]
[65]
Greco R, De Icco R, Demartini C, et al. Plasma levels of CGRP and expression of specific microRNAs in blood cells of episodic and chronic migraine subjects: Towards the identification of a panel of peripheral biomarkers of migraine? J Headache Pain 2020; 21(1): 122.
[http://dx.doi.org/10.1186/s10194-020-01189-0] [PMID: 33066724]
[66]
Scheffler A, Basten J, Menzel L, et al. Persistent effectiveness of CGRP antibody therapy in migraine and comorbid medication overuse or medication overuse headache - A retrospective real-world analysis. J Headache Pain 2024; 25(1): 109.
[http://dx.doi.org/10.1186/s10194-024-01813-3] [PMID: 38965463]
[67]
Nelson-Maney NP, Bálint L, Beeson ALS, et al. Meningeal lymphatic CGRP signaling governs pain via cerebrospinal fluid efflux and neuroinflammation in migraine models. J Clin Invest 2024; 134(15): e175616.
[http://dx.doi.org/10.1172/JCI175616] [PMID: 38743922]
[68]
Iyengar S, Johnson KW, Ossipov MH, Aurora SK. CGRP and the trigeminal system in migraine. Headache 2019; 59(5): 659-81.
[http://dx.doi.org/10.1111/head.13529] [PMID: 30982963]
[69]
Torun IE, Kilinc YB, Kilinc E, Töre F. TRESK channel activation ameliorates migraine-like pain via modulation of CGRP release from the trigeminovascular system and meningeal mast cells in experimental migraine models. Life Sci 2024; 357: 123091.
[http://dx.doi.org/10.1016/j.lfs.2024.123091] [PMID: 39362587]
[70]
Edvinsson L, Warfvinge K. Recognizing the role of CGRP and CGRP receptors in migraine and its treatment. Cephalalgia 2019; 39(3): 366-73.
[http://dx.doi.org/10.1177/0333102417736900] [PMID: 29020807]
[71]
Wang T, Zhu C. zhang K, et al. Targeting IGF1/IGF1r signaling relieve pain and autophagic dysfunction in NTG-induced chronic migraine model of mice. J Headache Pain 2024; 25(1): 156.
[http://dx.doi.org/10.1186/s10194-024-01864-6] [PMID: 39304806]
[72]
Ishibashi R, Itani M, Kawashima A, Arakawa Y, Aoki T. JNK2-MMP-9 axis facilitates the progression of intracranial aneurysms. Sci Rep 2024; 14(1): 19458.
[http://dx.doi.org/10.1038/s41598-024-70493-5] [PMID: 39169203]
[73]
Khan D, Cornelius JF, Muhammad S. The role of NF-κB in intracranial aneurysm pathogenesis: A systematic review. Int J Mol Sci 2023; 24(18): 14218.
[http://dx.doi.org/10.3390/ijms241814218] [PMID: 37762520]
[74]
Fan H, Tian H, Jin F, et al. CypD induced ROS output promotes intracranial aneurysm formation and rupture by 8-OHdG/] NLRP3/MMP9 pathway. Redox Biol 2023; 67: 102887.
[http://dx.doi.org/10.1016/j.redox.2023.102887] [PMID: 37717465]
[75]
Løvik K, Laupsa-Borge J, Logallo N, Helland CA. Body composition and rupture risk of intracranial aneurysms. Eur J Med Res 2024; 29(1): 297.
[http://dx.doi.org/10.1186/s40001-024-01888-3] [PMID: 38790007]
[76]
Etminan N, de Sousa DA, Tiseo C, et al. European stroke organisation (ESO) guidelines on management of unruptured intracranial aneurysms. Eur Stroke J 2022; 7(3): V.
[http://dx.doi.org/10.1177/23969873221099736] [PMID: 36082246]
[77]
Zuurbier CCM, Molenberg R, Mensing LA, et al. Sex difference and rupture rate of intracranial aneurysms: An individual patient data meta-analysis. Stroke 2022; 53(2): 362-9.
[http://dx.doi.org/10.1161/STROKEAHA.121.035187] [PMID: 34983236]
[78]
Dzator JSA, Howe PRC, Wong RHX. Profiling cerebrovascular function in migraine: A systematic review and meta-analysis. J Cereb Blood Flow Metab 2021; 41(5): 919-44.
[http://dx.doi.org/10.1177/0271678X20964344] [PMID: 33086920]
[79]
Chu HT, Liang CS, Lee JT, et al. Associations between depression/anxiety and headache frequency in migraineurs: A cross‐sectional study. Headache 2018; 58(3): 407-15.
[http://dx.doi.org/10.1111/head.13215] [PMID: 29044546]
[80]
Tfelt-Hansen PC. Evidence-based guideline update: Pharmacologic treatment for episodic migraine prevention in adults: Report of the quality standards subcommittee of the american academy of neurology and the american headache society. Neurology 2013; 80(9): 869-70.
[http://dx.doi.org/10.1212/01.wnl.0000427909.23467.39] [PMID: 23439705]
[81]
Ashina M. Migraine. N Engl J Med 2020; 383(19): 1866-76.
[http://dx.doi.org/10.1056/NEJMra1915327] [PMID: 33211930]

Rights & Permissions Print Cite